Compare INAB & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INAB | PETZ |
|---|---|---|
| Founded | 2016 | 2002 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 10.0M |
| IPO Year | 2021 | 2017 |
| Metric | INAB | PETZ |
|---|---|---|
| Price | $1.99 | $0.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $108.00 | N/A |
| AVG Volume (30 Days) | ★ 653.6K | 9.7K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $1,046,006.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.89 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.17 | $0.65 |
| 52 Week High | $12.53 | $1.68 |
| Indicator | INAB | PETZ |
|---|---|---|
| Relative Strength Index (RSI) | 59.88 | 38.35 |
| Support Level | $1.17 | $0.92 |
| Resistance Level | $1.87 | $1.05 |
| Average True Range (ATR) | 0.19 | 0.05 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 95.05 | 20.38 |
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.